Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

PHASE3RecruitingINTERVENTIONAL
Enrollment

538

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2026

Conditions
Ovarian Cancer
Interventions
DRUG

cisplatin

HIPEC with cisplatin after cytoreductive surgery

Trial Locations (28)

10065

RECRUITING

MSKCC New York, New York

91010

RECRUITING

City of Hope, Duarte

Unknown

RECRUITING

Rigshospitalet Copenhagen, Copenhagen

RECRUITING

CHU de Besancon, Besançon

RECRUITING

Institut Bergonié, Bordeaux

RECRUITING

o Institut Bergonié, Bordeaux, Bordeaux

RECRUITING

CHU Lille, Lille

RECRUITING

Centre Leon Berard, Lyon, Lyon

RECRUITING

CHU Lyon, Lyon

RECRUITING

Institut du Cancer Montpellier, Montpellier

RECRUITING

Institut de Cancerologie de l'Ouest, ICO Nantes), Nantes

RECRUITING

Institut Curie Paris, Paris

RECRUITING

CHRU Strasbourg, Strasbourg

RECRUITING

Oncopole, Institute Universitaire du Cancer de Toulouse (IUCT Toulouse), Toulouse

RECRUITING

Mater Misericordiae University Hospital, Dublin, Dublin

RECRUITING

Policlinico Sant'Orsola, Bologna, Bologna

RECRUITING

Fondazione Policlinico A Gemelli IRCCS, Roma

RECRUITING

Amsterdam UMC, Amsterdam

RECRUITING

Catharina Hospital, Eindhoven

RECRUITING

Medisch Spectrum Twente, Enschede

RECRUITING

UMCG, Groningen

RECRUITING

Leiden University Medical Center (LUMC), Leiden

RECRUITING

Maastricht UMC+, Maastricht

RECRUITING

Radboud MC, Nijmegen

RECRUITING

Erasmus MC, Rotterdam

RECRUITING

UMCU, Utrecht

RECRUITING

Alice Bjoernlund-Larsen, Uppsala

1066CX

RECRUITING

Antoni van leeuwenhoek, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER